Daixing Zhou
Impact in
-
- Traditional Chinese Medicine Analysis
Papers in
-
- Ubiquitin and proteasome pathways 2
- Signaling Pathways in Disease 2
- RNA modifications and cancer 1
-
- Cardiac Fibrosis and Remodeling 3
- Co-authors
- Jun Feng (6 shared papers)Junshuai Wang (6 shared papers)Min Wang (2 shared papers)Shusheng Li (3 shared papers)Fang Xu (1 shared paper)Fachun Zhou (1 shared paper)Shihui Lin (1 shared paper)Qiansheng Liang (3 shared papers)
- Journals
- International Immunopharmacology (1 paper)PLoS neglected tropical diseases (1 paper)Genes & Diseases (1 paper)Experimental Neurology (1 paper)Molecular and Cellular Biochemistry (1 paper)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Daixing Zhou
20 papers receiving 453 citations
Peers
Comparison fields: 5 of 81
- Complementary and alternative medicine 88
- Pharmacology 28
- Infectious Diseases 57
- Immunology 62
- Critical Care and Intensive Care Medicine 13
Countries citing papers authored by Daixing Zhou
This map shows the geographic impact of Daixing Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daixing Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daixing Zhou more than expected).
Fields of papers citing papers by Daixing Zhou
This network shows the impact of papers produced by Daixing Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daixing Zhou. The network helps show where Daixing Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Daixing Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 65 | |
| 2 | 2020 | 60 | |
| 3 | 2007 | 53 | |
| 4 | 2021 | 47 | |
| 5 | 2015 | 40 | |
| 6 | 2015 | 34 | |
| 7 | 2014 | 29 | |
| 8 | 2021 | 25 | |
| 9 | 2012 | 16 | |
| 10 | 2021 | 16 | |
| 11 | 2021 | 15 | |
| 12 | 2021 | 12 | |
| 13 | 2008 | 12 | |
| 14 | 2012 | 11 | |
| 15 | 2023 | 6 | |
| 16 | 2014 | 5 | |
| 17 | 2024 | 4 | |
| 18 | 2023 | 4 | |
| 19 | [Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A]. | 2008 | 4 |
| 20 | [Effects of tetrandrine on Ang II-induced cardiomyocyte hypertrophy and p-ERK1/2 expression]. | 2007 | 2 |
About Daixing Zhou
Daixing Zhou is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Complementary and alternative medicine, Pulmonary and Respiratory Medicine and Epidemiology, having authored 20 papers that have together received 460 indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (3 papers), Ubiquitin and proteasome pathways (2 papers), Traditional Chinese Medicine Analysis (2 papers), Respiratory Support and Mechanisms (2 papers), Signaling Pathways in Disease (2 papers), Sepsis Diagnosis and Treatment (2 papers), RNA modifications and cancer (1 paper) and Cardiac Ischemia and Reperfusion (1 paper). The work is most often cited by research in Complementary and alternative medicine (88 citations), Pharmacology (28 citations), Infectious Diseases (57 citations), Immunology (62 citations) and Critical Care and Intensive Care Medicine (13 citations). Daixing Zhou has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Jun Feng, Junshuai Wang, Min Wang, Shusheng Li, Fang Xu, Fachun Zhou, Shihui Lin, Qiansheng Liang, Ting Hao and Yang Pan. Their work appears in journals such as International Immunopharmacology, PLoS neglected tropical diseases, Genes & Diseases, Experimental Neurology and Molecular and Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.